Health
Efferon Battles Pediatric Sepsis with Blood-Purification Tech
Efferon, a Startup Battlefield 200 company, has developed innovative blood-purification technology aimed at reducing the devastating impact of pediatric sepsis. The medical startup addresses a critical healthcare gap by targeting both endotoxins and cytokines in children. With its flagship pediatric device, Efferon NEO, the company recently secured a CE mark in Europe and expanded into multiple international markets. The startup is now preparing for FDA approval as it continues to scale its life-saving interventions globally.